Drug Trial Radar · NCT06299826
A Phase IIb Study of AZD5462 in Patients With Chronic Heart Failure
Last checked: Nov 19, 2026Latest source record: Jul 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
375
Actual
Start
Jun 4, 2024
Primary completion
Feb 10, 2026
Study completion Feb 10, 2026
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Mar 8, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to evaluate the effect of AZD5462 on cardiac function in participants with chronic heart failure (HF).
Conditions
- Chronic Heart Failure
Interventions
AZD5462Drug
Participants will receive low, medium \& high doses of film-coated tablets of AZD5462 OD orally.
PlaceboDrug
Participants will receive matching doses of film-coated tablets of Placebo OD orally.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cohort A and B: Change from Baseline in Echocardiography ParametersTime frame: From Baseline to Week 25
Locations
57 sites in 10 countries. Site status is shown where the registry gives one.
Research Site
Alexander City, Alabama
Research Site
Northridge, California
Research Site
Torrance, California
Research Site
Vista, California
Research Site
Miami, Florida
Research Site
Miami Beach, Florida
Research Site
Richmond, Indiana
Research Site
Boston, Massachusetts
Research Site
Buffalo, New York
Research Site
Rosedale, New York
Research Site
Chapel Hill, North Carolina
Research Site
Philadelphia, Pennsylvania
Research Site
Knoxville, Tennessee
Research Site
Manassas, Virginia
Research Site
Pleven, Bulgaria
Research Site
Pleven, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Sofia, Bulgaria
Research Site
Brno, Czechia
Research Site
Jaroměř, Czechia
Research Site
Liberec, Czechia
Research Site
Louny, Czechia
Research Site
Pilsen, Czechia
Research Site
Aalborg, Denmark
Research Site
Herning, Denmark
Research Site
Balatonfüred, Hungary
Research Site
Kistarcsa, Hungary
Research Site
Nyíregyháza, Hungary
Research Site
Székesfehérvár, Hungary
Research Site
Kochi, India
Research Site
Kolkata, India
Research Site
Surat, India
Research Site
Vadodara, India
Research Site
Fukui-shi, Japan
Research Site
Higashiibaraki-gun, Japan
Research Site
Higashiohmi-shi, Japan
Research Site
Kitakyushu, Japan
Research Site
Kobe, Japan
Research Site
Kumamoto, Japan
Showing 40 of 57 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.